274 related articles for article (PubMed ID: 20425610)
1. Response assessment challenges in clinical trials of gliomas.
Wen PY; Norden AD; Drappatz J; Quant E
Curr Oncol Rep; 2010 Jan; 12(1):68-75. PubMed ID: 20425610
[TBL] [Abstract][Full Text] [Related]
2. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Wen PY; Macdonald DR; Reardon DA; Cloughesy TF; Sorensen AG; Galanis E; Degroot J; Wick W; Gilbert MR; Lassman AB; Tsien C; Mikkelsen T; Wong ET; Chamberlain MC; Stupp R; Lamborn KR; Vogelbaum MA; van den Bent MJ; Chang SM
J Clin Oncol; 2010 Apr; 28(11):1963-72. PubMed ID: 20231676
[TBL] [Abstract][Full Text] [Related]
3. Response assessment in neuro-oncology.
Quant EC; Wen PY
Curr Oncol Rep; 2011 Feb; 13(1):50-6. PubMed ID: 21086192
[TBL] [Abstract][Full Text] [Related]
4. Radiology: criteria for determining response to treatment and recurrence of high-grade gliomas.
Lucas J; Zada G
Neurosurg Clin N Am; 2012 Apr; 23(2):269-76, viii. PubMed ID: 22440870
[TBL] [Abstract][Full Text] [Related]
5. Pros and cons of current brain tumor imaging.
Ellingson BM; Wen PY; van den Bent MJ; Cloughesy TF
Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii2-11. PubMed ID: 25313235
[TBL] [Abstract][Full Text] [Related]
6. Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma.
Hygino da Cruz LC; Rodriguez I; Domingues RC; Gasparetto EL; Sorensen AG
AJNR Am J Neuroradiol; 2011 Dec; 32(11):1978-85. PubMed ID: 21393407
[TBL] [Abstract][Full Text] [Related]
7. Neuroradiological response criteria for high-grade gliomas.
Lutz K; Radbruch A; Wiestler B; Bäumer P; Wick W; Bendszus M
Clin Neuroradiol; 2011 Nov; 21(4):199-205. PubMed ID: 21681688
[TBL] [Abstract][Full Text] [Related]
8. Low-grade gliomas: when and how to treat.
Omay SB; Piepmeier JM; Knisely JP
Hematol Oncol Clin North Am; 2012 Aug; 26(4):797-809. PubMed ID: 22794284
[TBL] [Abstract][Full Text] [Related]
9. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.
Vogelbaum MA; Jost S; Aghi MK; Heimberger AB; Sampson JH; Wen PY; Macdonald DR; Van den Bent MJ; Chang SM
Neurosurgery; 2012 Jan; 70(1):234-43; discussion 243-4. PubMed ID: 21593697
[TBL] [Abstract][Full Text] [Related]
10. Imaging endpoints in brain tumor clinical trials: proceedings of the January 30, 2014 Workshop. Introduction.
Yung WK
Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii1. PubMed ID: 25313233
[No Abstract] [Full Text] [Related]
11. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.
Shah GD; Kesari S; Xu R; Batchelor TT; O'Neill AM; Hochberg FH; Levy B; Bradshaw J; Wen PY
Neuro Oncol; 2006 Jan; 8(1):38-46. PubMed ID: 16443946
[TBL] [Abstract][Full Text] [Related]
12. [Research and therapeutic trials on gliomas].
Ducray F
Soins; 2009 Mar; (733):51. PubMed ID: 19366007
[No Abstract] [Full Text] [Related]
13. Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies.
Keunen O; Taxt T; Grüner R; Lund-Johansen M; Tonn JC; Pavlin T; Bjerkvig R; Niclou SP; Thorsen F
Adv Drug Deliv Rev; 2014 Sep; 76():98-115. PubMed ID: 25078721
[TBL] [Abstract][Full Text] [Related]
14. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.
Galanis E; Buckner JC; Maurer MJ; Sykora R; Castillo R; Ballman KV; Erickson BJ
Neuro Oncol; 2006 Apr; 8(2):156-65. PubMed ID: 16533757
[TBL] [Abstract][Full Text] [Related]
15. [Perspectives in diagnosis and management of malignant gliomas].
Psimaras D; Delattre JY
Cancer Radiother; 2008 Nov; 12(6-7):695-700. PubMed ID: 18829366
[TBL] [Abstract][Full Text] [Related]
16. Response assessment in neuro-oncology criteria: implementation challenges in multicenter neuro-oncology trials.
Pope WB; Hessel C
AJNR Am J Neuroradiol; 2011 May; 32(5):794-7. PubMed ID: 21474628
[No Abstract] [Full Text] [Related]
17. Imaging biomarkers for antiangiogenic therapy in malignant gliomas.
Leu K; Pope WB; Cloughesy TF; Lai A; Nghiemphu PL; Chen W; Liau LM; Ellingson BM
CNS Oncol; 2013 Jan; 2(1):33-47. PubMed ID: 24570837
[TBL] [Abstract][Full Text] [Related]
18. Treatment of low-grade pediatric gliomas.
Schmandt SM; Packer RJ
Curr Opin Oncol; 2000 May; 12(3):194-8. PubMed ID: 10841190
[TBL] [Abstract][Full Text] [Related]
19. Low Grade Gliomas in Children.
Chalil A; Ramaswamy V
J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
[TBL] [Abstract][Full Text] [Related]
20. [Latest treatment strategies for malignant gliomas].
Shono T; Mizoguchi M; Sasaki T
Fukuoka Igaku Zasshi; 2007 Sep; 98(9):333-6. PubMed ID: 17974076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
